Brigid Makes - Jun 1, 2022 Form 4/A - Amendment Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role: Director
Signature: /s/ Robert Barrow, Attorney-in-Fact
Stock symbol: MNMD
Transactions as of: Jun 1, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 6/6/2022, 04:14 PM
Date Of Original Report: Jun 3, 2022
Previous filing: May 24, 2022
Next filing: Jun 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MNMD	Subordinate Voting Shares	Award	$0	+64.7K	+68.75%	$0.00	159K	Jun 1, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MNMD	Stock Option (Right to Buy)	Award	$0	+100K	+106.65%	$0.00	194K	Jun 1, 2022	Subordinate Voting Shares	100K	$0.60	Direct	F2, F3
transaction	MNMD	Director's Deferred Share Units	Award		+362K	+128.2%		644K	Jun 1, 2022	Subordinate Voting Shares			Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in equal installments over 36 months beginning on June 1, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
F2	The option grant has an exercise price of $0.75 Canadian Dollars. This represents the exercise price in United States Dollars.
F3	1/3rd of the shares underlying the option vest and become exercisable on June 1, 2023; the remaining 2/3rds of the shares underlying the option shall vest in equal installments, vesting at the end of each month thereafter for the succeeding 24 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
F4	Represents Directors' Deferred Share Units ("DDSUs") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the "Plan"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators (defined in the Plan).

Remarks:

Explanatory Note: This Amendment on Form 4/A is being filed to amend the Form 4 filed on June 3, 2022 solely to update the Expiration Date of the Stock Option in Table 2.